FOXD1 and lip and oral cavity carcinoma: Knockdown of FOXD1 could significantly inhibite the colony-forming ability of oral cancer cells after radiotherapy and enhance the expression of TXNIP via the JAK-STAT signalling pathway (Lin et al., 2020).